News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Sankalp Arora: Sharing our ASCO25 Abstract – Relapse Mechanisms After FLT3i therapy in Frontline AML
Sankalp Arora/X
May 24, 2025, 07:00

Sankalp Arora: Sharing our ASCO25 Abstract – Relapse Mechanisms After FLT3i therapy in Frontline AML

Sankalp Arora, Hematology/Medical Oncology Fellow at MD Anderson Cancer Center, shared in a post on X:

“Sharing our ASCO25 abstract: relapse mechanisms after FLT3i rx in frontline AML.

FLT3 loss and emergent DNA methylation/RAS-MAPK/WT1 mutations were common at relapse. Post SCT relapses were less likely to be driven by emergent mutations.”

 

ASCO25 cancer OncoDaily Oncology Sankalp Arora
Special Coverage
Voices
Sep 5, 2025, 10:18
Isabel Mestres: I Recently Contributed with an Op-Ed to Resolve Global Health’s New Report
Dialogues
Sep 5, 2025, 10:12
MASCC 2025 Presidential Training Fellowship Spotlight: Celia Díez de los Ríos de la Serna
Voices
Sep 5, 2025, 10:11
Staying Physically Active Isn't Just Personal Care: It's Professional Responsibility - American Cancer Society
Voices
Sep 5, 2025, 09:55
Florian Lordick: Chemoresistance of Novel Therapeutic Approaches for Esophageal Adenocarcinoma
Science
Sep 5, 2025, 09:41
Vivek Subbiah: How Aggressive Brain Tumors Exploit Glucose to Suppress Normal Activity
Voices
Sep 5, 2025, 08:57
Honoring a Life of Compassion and Impact - CancerWorld
Voices
Sep 5, 2025, 08:57
C/Can Advances Breast Imaging Training for Global Cities
FDA Approvals
Sep 5, 2025, 08:44
Olomorasib Receives FDA Breakthrough Therapy Designation for KRAS G12C-Mutant NSCLC
Voices
Sep 5, 2025, 08:36
Miriam Mutebi: Scalpel-Wielding Surgeon is Terrified of Needles - Especially When They’re Aimed at Me
Dialogues
Sep 5, 2025, 08:09
ONCOFFEE: Gabriela Inés Villanueva – From Argentina to the US and Back, Shaping Pediatric Oncology
Dialogues
Sep 5, 2025, 08:07
Roche’s CMO Levi Garraway on Personal Journey, Developing Foundation Medicine, and Cancer Research
Dialogues
Sep 5, 2025, 08:05
What Happens When Cancer Meets a Global Pandemic? | Patient stories